da an gene co ltd sun yat-a
(002030:Shenzhen)
da an gene co ltd sun yat-a (002030) Snapshot
|
Open
CNY11.71
|
Previous Close
CNY11.33
|
|
|
Day High
CNY12.30
|
Day Low
CNY11.38
|
|
|
52 Week High
05/23/13 - CNY12.30
|
52 Week Low
12/4/12 - CNY6.03
|
|
|
Market Cap
4.8B
|
Average Volume 10 Days
30.9M
|
|
|
EPS TTM
CNY0.24
|
Shares Outstanding
416.0M
|
|
|
EX-Date
--
|
P/E TM
48.6x
|
|
|
Dividend
CNY0.01
|
Dividend Yield
0.17%
|
Related News
da an gene co ltd sun yat-a (002030) Related Businessweek News
No Related Businessweek News Foundda an gene co ltd sun yat-a (002030) Details
Da An Gene Co., Ltd. engages in the research and development, production, and service of in-vitro diagnostic products. The company offers real-time polymerase chain reaction instruments and kits; ELISA HIV antibody and HBsAg diagnostic kits; TRF kits and analyzers; and RAPID diagnostic kits and equipment; food safety products; and pathology products, including automatic liquid-based preparation systems, as well as clinical test services. It also provides molecular diagnostic and analytical instruments; technology products in the areas of genetic engineering, cellular engineering, bio-chemical engineering, and immune labeling; and medical diagnostic devices, and reagents and consumables related to clinical biochemistry, immunology, microbiology, pathology, and histology, as well as offers technical services and information consulting services. In addition, the company researches and develops time-resolved immunoassay technology and time-resolved immunofluorometric diagnostic kits. Da An Gene Co., Ltd. was founded in 1993 and is headquartered in Guangzhou, the People’s Republic of China.
da an gene co ltd sun yat-a (002030) Key Developments
Da An Gene Co Ltd. announced that the 3rd Extraordinary General Meeting of shareholders of the company was held on May 16, 2013, approved the amendments to the Articles of Association of the company.
Da An Gene Co Ltd. announced that at its Extraordinary General Meeting will be held on May 16, 2013, the shareholders proposed the amendments to the company's articles of association.
Da An Gene Co Ltd. announced that they will report Q1, 2013 results on Apr 26, 2013
| Recently Viewed | |||
| 002030:CH | CNY11.58 CNY | +0.25 | |
| Company | Last | Change | |
| No competitor information is available for 002030. | |||
| View Industry Companies | |||
Industry Analysis
002030
Industry Average
| Valuation | 002030 | Industry Range |
| Price/Earnings | 45.8x |
|
| Price/Sales | 7.4x |
|
| Price/Book | 7.8x |
|
| Price/Cash Flow | 47.4x |
|
| TEV/Sales | 7.1x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact DA AN GENE CO LTD SUN YAT-A, please visit www.daangene.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








